Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration

被引：0
|
作者：
A. Dallob
I. De Lepeleire
A. Van Hecken
A. Porras
M. Depré
S. Mukhopadhyay
M. Flynn
L. Wildonger
K. Gottesdiener
W. Tanaka
P. De Schepper
机构：
[1] Merck & Co.,
[2] Inc.,undefined
[3] P. O. Box 2000,undefined
[4] Rahway,undefined
[5] NJ 07065,undefined
[6] USA,undefined
[7] Fax +17325947804,undefined
[8] e-mail: aimee_dallob@merck.com,undefined
[9] U. Z. Gasthuisberg,undefined
[10] Herestraat 49,undefined
[11] B-3000 Leuven,undefined
[12] Belgium,undefined
来源：
Inflammation Research | 1999年 / 48卷 / Suppl 2期
关键词：
Single Dose; Dose Administration; Single Dose Administration;
D O I：
10.1007/s000110050552
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：130 / 131
页数：1
相关论文
共 12 条
  • [1] Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration
    Dallob, A
    De Lepeleire, I
    Van Hecken, A
    Porras, A
    Depré, M
    Mukhopadhyay, S
    Flynn, M
    Wildonger, L
    Gottesdiener, K
    Tanaka, W
    De Schepper, P
    INFLAMMATION RESEARCH, 1999, 48 : S130 - S131
  • [2] Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor
    Reinhold, SW
    Fischereder, M
    Riegger, GAJ
    Krämer, BK
    CLINICAL NEPHROLOGY, 2003, 60 (04) : 295 - 296
  • [3] Single dose tolerability and pharmacokinetics of parecoxib sodium, a COX-2 specific inhibitor, following intravenous administration.
    Karim, A
    Laurent, A
    Qian, J
    Kuss, M
    Hubbard, R
    ANESTHESIOLOGY, 2000, 93 (3A) : U204 - U204
  • [4] Evaluation of the Genotoxic Potential of the Selective COX-2 Inhibitor Enflicoxib in a Battery of in vitro and in vivo Genotoxicity Assays
    Guzman, Antonio
    Homedes, Josep
    Salichs, Marta
    DRUG RESEARCH, 2022, 72 (03) : 163 - 170
  • [5] The Effect of a Single Dose of Preemptive Pregabalin Administered With COX-2 Inhibitor: A Trial in Total Knee Arthroplasty
    Lee, Jin Kyu
    Chung, Kyu-Sung
    Choi, Choong Hyeok
    JOURNAL OF ARTHROPLASTY, 2015, 30 (01): : 38 - 42
  • [6] The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment
    de Boer, T. N.
    Huisman, A. M.
    Polak, A. A.
    Niehoff, A. G.
    van Rinsum, A. C.
    Saris, D.
    Bijlsma, J. W. J.
    Lafeber, F. J. P. G.
    Mastbergen, S. C.
    OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (04) : 482 - 488
  • [7] Mitigation of arthritis by high-dose administration of a COX-2 inhibitor in the collagen-induced arthritis model in the mouse
    Obukowicz, MG
    Ornberg, RL
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION INJURY, 4, 1999, 469 : 145 - 150
  • [8] Licofelone, an inhibitor of COX-1, COX-2 and 5-LOX, has an excellent tolerability profile when given in single doses of up to 16-fold the therapeutic dose
    Bias, P
    Buchner, A
    Lammerich, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 479 - 479
  • [9] CO-ADMINISTRATION OF SUBTHERAPEUTIC DIAZEPAM ENHANCES NEUROPROTECTIVE EFFECT OF COX-2 INHIBITOR, NS-398, AFTER LITHIUM PILOCARPINE-INDUCED STATUS EPILEPTICUS
    Trandafir, C. C.
    Pouliot, W. A.
    Dudek, F. E.
    Ekstrand, J. J.
    NEUROSCIENCE, 2015, 284 : 601 - 610
  • [10] Comparison of duration of metaphase in CD1 mice 24 h after NSAID administration: indomethacin vs. the 'gut-sparing' Cox-2 inhibitor nimesulide
    不详
    JOURNAL OF ANATOMY, 2005, 206 (05) : 513 - 513
12